Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01351935
Recruitment Status : Completed
First Posted : May 11, 2011
Last Update Posted : August 27, 2015
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
Celgene ( Celgene Corporation )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2015
  Study Completion Date : June 2015